Outcomes of Endoscopic Resection of Mucosal and Submucosal Lesions in the Stomach
NCT ID: NCT02306707
Last Updated: 2025-03-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2014-10-31
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-term Outcomes of Endoscopic Resection (ER) of Lesions of the Duodenum and Ampulla
NCT02306603
The Australian Colonic Advanced Mucosal Neoplasia and Endoscopic Resection Study
NCT02000141
Upper GI Outcomes Following EMR
NCT02305290
Cold Snare Polypectomy Versus Endoscopic Mucosal Resection for Colonic Sessile Serrated Polyps
NCT02967107
Australian Multicentre Colonic Endoscopic Mucosal Resection Study
NCT01368289
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Endoscopic Mucosal Resection
Patients who are referred for Endoscopic Mucosal Resection of Stomach Lesions will be included in this cohort.
Endoscopic Mucosal Resection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endoscopic Mucosal Resection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Lesion limited to the mucosal and/or submucosal layer (T1 lesion)
* Aged 18 years or older
Exclusion Criteria
* Stomach lesion involves the muscularis propria (T2 lesion) on other staging modalities such as endoscopic ultrasonography (EUS)
* Aged younger than 18 years
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Professor Michael Bourke
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Professor Michael Bourke
Director of Gastrointestinal Endoscopy
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael J Bourke, MBBS
Role: PRINCIPAL_INVESTIGATOR
Western Sydney Local Health District
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Westmead Hospital Endoscopy Unit
Sydney, New South Wales, Australia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wang H, Nguyen M, Gupta S, Sidhu M, Cronin O, O'Sullivan T, Whitfield A, Lee EYT, Burgess NG, Bourke MJ. Long-term outcomes after endoscopic submucosal dissection for relative indication early gastric cancer in nonsurgical candidates. Gastrointest Endosc. 2024 Oct;100(4):647-659. doi: 10.1016/j.gie.2024.03.032. Epub 2024 Apr 3.
Tate DJ, Klein A, Sidhu M, Desomer L, Awadie H, Lee EYT, Mahajan H, McLeod D, Bourke MJ. Endoscopic submucosal dissection for suspected early gastric cancer: absolute versus expanded criteria in a large Western cohort (with video). Gastrointest Endosc. 2019 Sep;90(3):467-479.e4. doi: 10.1016/j.gie.2019.04.242. Epub 2019 May 8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HREC2014/5/4.1 (3970)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.